Disparities in the Receipt of Immunotherapy for Patients With Head and Neck Mucosal Melanoma
Despite increasing IT use, no disparities in access or survival by SES were observed. While survival improved modestly over time, IT was not independently associated with this trend. These findings highlight equitable IT use in HNMM and underscore the need for future prospective studies to clarify its survival impact.
Authors
- Joshua B. Smith (ORCID: https://orcid.org/0000-0002-7131-669X)
- Sean T. Massa (ORCID: https://orcid.org/0000-0003-2015-9855)
- Areeb Shah (ORCID: https://orcid.org/0009-0008-3555-8641)
- Peter Q. Luong
- Matthew C. Simpson (ORCID: https://orcid.org/0000-0001-9476-1326)
Institutions
- Saint Louis University (US)
Publication Details
- Journal
- Laryngoscope Investigative Otolaryngology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/lio2.70232
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00